Physician profile
Ashley Walton
NPI 1518443803
$5,567.04
in general payments reported to CMS, 2019-2025
44 companies · $1,656 in 2025
The $1,656 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $769 · 2022: $651 · 2023: $608 · 2024: $1,883 · 2025: $1,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,102 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,102.03 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $942.49 | 2021-2025 | Enbrel, Otezla, Otezla |
| Janssen Biotech, INC. | $802.65 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Ucb, INC. | $667.26 | 2022-2025 | Cimzia, Bimzelx |
| Abbvie INC. | $460.04 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $398.07 | 2022-2025 | Acthar |
| E.R. Squibb & Sons, L.L.C. | $311.90 | 2021-2025 | Orencia |
| Glaxosmithkline, LLC. | $214.19 | 2021-2025 | Benlysta, Jemperli, Zejula |
| Lilly USA, LLC | $194.26 | 2021-2025 | Taltz |
| Fresenius Kabi USA, LLC | $129.18 | 2023-2025 | Idacio, Tyenne |
| Astrazeneca Pharmaceuticals LP | $127.03 | 2021-2025 | Saphnelo |
| Radius Health, INC. | $118.91 | 2024-2025 | Tymlos |
| Aurinia Pharma U.S., INC. | $115.67 | 2022-2025 | Lupkynis |
| Celgene Corporation | $112.15 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.30 | 2024-2025 | Ofev |
| Seagen INC. | $73.34 | 2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.